We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Campylobacter Rely on Pseudomonas to Infect Humans

By LabMedica International staff writers
Posted on 27 Oct 2010
The interaction between the different species of bacteria seems to be a mechanism for Campylobacter jejuni to remain viable and survive ambient oxygen levels. More...


C. jejuni is a microaerophilic gram-negative bacillus that causes febrile diarrhea or dysentery; vomiting or bloody stool are often noted with severe abdominal pain. The disease is most common among children and lasts one to four days.

Although Campylobacter infections are rarely life threatening, they are extremely debilitating and they have been linked with the development of Guillain-Barré syndrome, one of the leading causes of nontrauma-induced paralysis worldwide. The bacteria do not grow well at room temperature or in an oxygen-rich environment as it well adapted to life in the intestines of animals and humans. However, it is normally transmitted from contaminated chicken meat, as it is frequently found in the intestines of chickens, where it apparently does not result in any symptoms.

Scientists at the University of Veterinary Medicine (Vienna, Austria), have recently discovered that interactions with other bacteria allow C. jejuni to survive under hostile, oxygen-rich conditions. Campylobacter survived atmospheric oxygen levels for no longer than 18 hours when incubated alone or together with bacteria such as Proteus mirabilis, Citrobacter freundii, Micrococcus luteus or Enterococcus faecalis. However, when incubated together with various strains of Pseudomonas, Campylobacter were found to survive for much longer, in some cases over 48 hours, which would be easily long enough to cause infection. An in vitro assay was used to test the bacteria's survival rate.

There were differences in the extent of prolonged survival depending on the sources of the Campylobacter analyzed, but all isolates of all strains clearly survived significantly longer in the presence of Pseudomonas bacteria than when cultured alone. And the Campylobacter cells did not change shape when cultured together with Pseudomonas under oxygen-rich conditions, unlike when they were cultured alone, providing further indications of an interaction between the species. Interestingly, there is no evidence that the Pseudomonas benefit at all from the interaction, although they effectively facilitate the survival of Campylobacter under adverse conditions.

This microbial commensalism was diverse in C. jejuni isolates from different sources: isolates from chicken meat and humans in coculture with Ps. putida were able to use this survival support better than fecal isolates from broilers. Scanning electron microscopy revealed the development of fiber-like structures braiding Ps. putida and C. jejuni cells. Hence, it seems that microaerophilic C. jejuni is able to survive ambient atmospheric oxygen tension by metabolic commensalism with Pseudomonas species. This bacterial-bacterial interaction might set the basis for the survival of C. jejuni on chicken meat and thus be the prerequisite step in the pathway towards human infection. The study was published the October 2010 issue of Applied and Environmental Microbiology.

Related Links:
University of Veterinary Medicine




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.